
Enzymaster’s Sanming Minhe Acquisition Increases Production Capacity by 50% to Keep Pace with Rapidly Growing Demand
Sanming Minhe will be the primary facility for pharmaceutical intermediates and additional compounds produced leveraging Enzymaster technology. DüSSELDORF, GERMANY, January 11, 2022 /EINPresswire.com/ -- Across a range of industries, including …